Special Topic
Topic: Latest Advances in Primary Immunodeficiency Diseases
A Special Topic of Rare Disease and Orphan Drugs Journal
ISSN 2771-2893 (Online)
Submission deadline: 30 Jun 2025
Guest Editor
Special Topic Introduction
Primary Immunodeficiency Diseases (PID) are a group of rare, chronic disorders in which part of the body's immune system is missing or functions improperly. These diseases are usually inherited and can present in a variety of ways, often leading to increased susceptibility to infections, autoimmune disorders, and in some cases, an increased risk of cancer.
The significance of PIDs lies in their complex nature, which necessitates a multifaceted research approach. This Special Issue aims to encapsulate the latest advancements and comprehensive insights into PIDs, covering several critical areas:
● Genetic Research;
● Immunological Mechanisms;
● Clinical Phenotypes and Disease Spectrum;
● Diagnostic Technologies;
● Treatment Approaches;
● Patient Management and Care.
This Special Issue aims to provide a comprehensive overview of the current state of PID research, highlighting the advancements, challenges, and future directions. Through a deeper understanding of these multifaceted diseases, the goal is to improve diagnosis, management, and outcomes for individuals affected by PIDs.
The significance of PIDs lies in their complex nature, which necessitates a multifaceted research approach. This Special Issue aims to encapsulate the latest advancements and comprehensive insights into PIDs, covering several critical areas:
● Genetic Research;
● Immunological Mechanisms;
● Clinical Phenotypes and Disease Spectrum;
● Diagnostic Technologies;
● Treatment Approaches;
● Patient Management and Care.
This Special Issue aims to provide a comprehensive overview of the current state of PID research, highlighting the advancements, challenges, and future directions. Through a deeper understanding of these multifaceted diseases, the goal is to improve diagnosis, management, and outcomes for individuals affected by PIDs.
Submission Deadline
30 Jun 2025
Submission Information
For Author Instructions, please refer to https://www.oaepublish.com/rdodj/author_instructions
For Online Submission, please login at https://www.oaecenter.com/login?JournalId=rdodj&IssueId=rdodj2504302117
Submission Deadline: 30 Jun 2025
Contacts: Cyndi Guan, Assistant Editor, [email protected]
Published Articles
Gene therapy for inborn errors of immunity: past progress, current status and future directions
Open Access Review 16 Oct 2025
Views: Downloads:






